Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Celator Pharmaceuticals

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Princeton, New Jersey, United States Founded 1999 11-50 employees For Profit

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

Celator Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Celator Pharmaceuticals was acquired by Jazz Pharmaceuticals in 2016 for $1.5B.
Total Funding
$155.57M
Funding Rounds
10
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
Patents
16
9 trademarks

About Celator Pharmaceuticals

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Delisted
Ticker
CPXX
Exchange
NASDAQ
IPO date
Sep 13, 2013
Delisted
Jul 12, 2016

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
6
Active products
4
Patents granted
16
Trademarks
9
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$8.82M

Company Info

Founded
1999
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
News articles
54
HQ
Princeton, New Jersey, United States
Region
East Coast, Northeastern US
Exit date
Sep 13, 2013

Signals & Scores

Heat score
Low
Trend (7d)
-0.9
Trend (30d)
-1.4
Trend (90d)
-0.9

Celator Pharmaceuticals Funding Rounds

10 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–5 of 10Show
Page 1 / 2

Celator Pharmaceuticals Key People

CBO
CEO
Founder, President & CSO
CMO

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Celator Pharmaceuticals

Loading news…

FAQs about Celator Pharmaceuticals

People who checked this page also checked these

Browse the full Acquirezy directory.